LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Monoclonal Antibodies and Airway Diseases

    Annina Lyly / Anu Laulajainen-Hongisto / Philippe Gevaert / Paula Kauppi / Sanna Toppila-Salmi

    International Journal of Molecular Sciences, Vol 21, Iss 9477, p

    2020  Volume 9477

    Abstract: Monoclonal antibodies, biologics, are a relatively new treatment option for severe chronic airway diseases, asthma, allergic rhinitis, and chronic rhinosinusitis (CRS). In this review, we focus on the physiological and pathomechanisms of monoclonal ... ...

    Abstract Monoclonal antibodies, biologics, are a relatively new treatment option for severe chronic airway diseases, asthma, allergic rhinitis, and chronic rhinosinusitis (CRS). In this review, we focus on the physiological and pathomechanisms of monoclonal antibodies, and we present recent study results regarding their use as a therapeutic option against severe airway diseases. Airway mucosa acts as a relative barrier, modulating antigenic stimulation and responding to environmental pathogen exposure with a specific, self-limited response. In severe asthma and/or CRS, genome–environmental interactions lead to dysbiosis, aggravated inflammation, and disease. In healthy conditions, single or combined type 1, 2, and 3 immunological response pathways are invoked, generating cytokine, chemokine, innate cellular and T helper (Th) responses to eliminate viruses, helminths, and extracellular bacteria/fungi, correspondingly. Although the pathomechanisms are not fully known, the majority of severe airway diseases are related to type 2 high inflammation. Type 2 cytokines interleukins (IL) 4, 5, and 13, are orchestrated by innate lymphoid cell (ILC) and Th subsets leading to eosinophilia, immunoglobulin E (IgE) responses, and permanently impaired airway damage. Monoclonal antibodies can bind or block key parts of these inflammatory pathways, resulting in less inflammation and improved disease control.
    Keywords airways ; asthma ; chronic rhinosinusitis ; biologicals ; monoclonal antibody ; Biology (General) ; QH301-705.5 ; Chemistry ; QD1-999
    Subject code 610
    Language English
    Publishing date 2020-12-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article: Lung function and side effects of Aspirin desensitization: a real world study.

    Heikki, Turpeinen / Anu, Laulajainen-Hongisto / Annina, Lyly / Jura, Numminen / Elina, Penttilä / Sahlman, Johanna / Sanna, Toppila-Salmi / Paula, Kauppi

    European clinical respiratory journal

    2021  Volume 8, Issue 1, Page(s) 1869408

    Abstract: ... ...

    Abstract Introduction
    Language English
    Publishing date 2021-01-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2834928-3
    ISSN 2001-8525 ; 1399-3003 ; 2001-8525 ; 0903-1936
    ISSN (online) 2001-8525 ; 1399-3003
    ISSN 2001-8525 ; 0903-1936
    DOI 10.1080/20018525.2020.1869408
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top